New Screening May Help Predict Preeclampsia Earlier in Pregnancies
George Washington University
Researchers at UT Southwestern Medical Center have developed a novel artificial intelligence (AI) model to improve the detection of breast cancer metastasis, which could reduce the need for needle or surgical biopsies.
Brown fat metabolism decreases in older men and women, but the decrease in women is not necessarily tied to age, according to new research. The first-of-its-kind study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism and has been chosen as an APSselect article for May.
MAYWOOD, IL - Loyola Medicine proudly announces the launch of its Women's Sports Medicine (WSM) program, a groundbreaking initiative dedicated exclusively to the health care needs of female athletes. This landmark program stands as the first of its kind in the Chicagoland area, offering a comprehensive, interdisciplinary approach to sports medicine for women and girls.
Women’s health doctors and researchers will share new insights on prenatal care
A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant.
Rutgers Health researchers tie infertility treatment to a particular risk for hypertensive diseases.
A UCLA-led study suggests women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.
Cedars-Sinai investigators are using artificial intelligence (AI) to reduce serious health risks associated with pregnancy and childbirth and improve screening for some gynecological cancers.
Ruth D. Stephenson, DO, FACOG, gynecologic oncologist in the Gynecologic Oncology Program at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health shares tips for women to live their healthiest lives.
Dr. Ndidiamaka Amutah-Onukagha explores the historical and contemporary reproductive struggles faced by women of color in the United States, highlighting challenges such as medical bias, unequal access to resources, and inadequate prenatal care, while also discussing environmental influences on maternal and child health and community engagement strategies.
A recent review article provides critical insights into the management of acute agitation in reproductive-age females and during pregnancy within the emergency departments (EDs).
The Society for Clinical Trials (SCT) is pleased to announce that the prestigious David Sackett Trial of the Year Award will be presented to the ”Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage (E-MOTIVE).”
Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk. Yet for decades, BV treatment in the United States has largely relied on antibiotics, and BV recurrence is common following antibiotic therapy.
A University of California, Irvine-led team has found evidence of a potential link between patterns of changes in a key pregnancy hormone – placental corticotropin-releasing hormone – and symptoms of postpartum depression.
Drs. Kachikis and Eckert stressed that more research and funding are needed, specifically in treatments that might help women remain pregnant while fighting cancers and other diseases.
John Theurer Cancer Center physician blazes medical trail and now Mt. Kilimanjaro
Challenges remain in ensuring equitable access to screening and addressing gaps in evidence regarding supplemental screening modalities and the adoption of artificial intelligence (AI) technologies, notes Joann Elmore, MD, MPH, a professor of medicine at the David Geffen School of Medicine at UCLA in a newly published editorial in JAMA.
The final United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Recommendations, while an improvement over previous guidance, do not go far enough to save more women’s lives. Women at average risk for breast cancer should start annual screening at age 40.
“Hackensack Meridian Health is a regional leader in high quality Obstetrics & Gynecology procedures,” said Todd Way, president, central region, Hackensack Meridian Health. “I’m thrilled to welcome Dr. Kayaalp. His expertise, leadership skills, and commitment to patient care will be invaluable to our organization.”
Ageless and evergreen: The signature lyric that sums up Robin Lipman’s reverence for one of the most iconic entertainers of our time. That epic level of fan appreciation would manifest in a fundraising campaign to benefit the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute at Cedars-Sinai.
Investigators in the Smidt Heart Institute at Cedars-Sinai and colleagues report that women with Type 2 diabetes diagnosed with hypertension before age 50 may benefit from intensive blood pressure treatment.
Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showing the performance of its Mercy Halo™ Ovarian Cancer screening test in a large cohort of asymptomatic, postmenopausal women.
When exposed to stress, people with alcohol use disorder engage parts of the brain associated with both stress and addiction, which may cause them to drink or crave alcohol after a stressful experience, suggest the authors of a study published in Alcohol: Clinical and Experimental Research.
A new study from the University of South Australia is putting people’s experiences of pelvic pain at the front of pain education to develop better pain management strategies and improved outcomes.
Cleveland Clinic has announced the launch of its new Women’s Comprehensive Health and Research Center, an initiative dedicated to helping women during midlife and beyond thrive and easily receive the specialized care they need. The center is focused on four key areas: access, connectivity, education, and research and innovation to empower women to navigate their health journey with confidence and clarity.
A Rutgers Health study ties quitting to more hypertensive disorders but fewer premature deliveries and stillbirths.
In a new study, a Johns Hopkins Medicine-led research team reports that social stress during adolescence in female mice later results in prolonged elevation of the hormone cortisol after they give birth.
Women who take oral contraceptives may be significantly less likely to experience certain musculoskeletal injuries than women who do not take the drugs or men, according to a study by UT Southwestern Medical Center.
New Jersey Economic Development Authority taps Rutgers-led consortium as educational component of a new maternal and infant health innovation center.
A third of the nearly 20 million women who participated in a national health survey reports migraines during menstruation, and of them, 11.8 million, or 52.5%, were premenopausal.
The National Institutes of Health (NIH) has awarded University of Idaho more than $11 million toward creating a biomedical research center focused on furthering studies on women’s health and nutrition.
Rutgers Health researchers identify patients at risk for preventable death in the year after pregnancy.
Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.
Cervical cancer, often caused by persistent human papillomavirus (HPV) infections, remains a public health challenge worldwide despite falling diagnoses related to the success of the HPV vaccine[GR1] in young adult women.
Black women in the U.S. are three times more likely than white women to die, or become seriously ill, from pregnancy-related complications, according to the Centers for Disease Control and Prevention. Addressing the complexity of causes behind poor health outcomes for Black mothers requires commitment, investment and innovation to produce measurable change.
The Federation of American Societies for Experimental Biology (FASEB) bestows its highest honor, FASEB Excellence in Science Awards, to three women scientists.
Labor induction with vaginal misoprostol during childbirth achieves vaginal delivery rates similar to the oral alternative while significantly reducing the need for oxytocin, the most commonly used labor-inducing drug, UT Southwestern Medical Center researchers report.
In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators, a novel combination of an antibody-drug conjugate and an immune checkpoint inhibitor showed notable activity in pre-treated patients with a difficult-to-treat form of endometrial cancer. In this study, tumors were reduced in six out of 16 patients treated with the combination, including one case in which the cancer disappeared.
The Neil B. Rosenshein, M.D., Institute for Gynecologic Care at Mercy Medical Center in Baltimore, MD, presents the 9th Annual Women's Health Symposium, a premier medical education opportunity for nurse practitioners and physician assistants.